top of page
telehealth-1024x683.jpg

HOME   -   POST

POST

Search

Sleep, Mood & Brain Fog in Perimenopause and Menopause: Understanding Evidence-Based Management Pathways [Menopause Symptoms & Systems Series (Part 3 of 3)]

In Part 1, we explored why sleep and fatigue commonly change during perimenopause and menopause, and why these symptoms are often multifactorial.


In Part 2, we looked at why sleep disturbance, anxiety, low mood, and cognitive symptoms such as “brain fog” so often occur together — and why they are best understood as interconnected systems.



In Part 3, we bring this together by outlining how clinicians think about evidence-based management pathways for these symptoms, and why an individualised, stepwise approach is supported by current clinical guidance.


Why there is no single “right” treatment

Because sleep disturbance, mood changes, anxiety, and cognitive symptoms are influenced by multiple overlapping factors, there is no one-size-fits-all solution.

Management is most effective when it:

  • Identifies the dominant contributors for that individual

  • Prioritises symptoms that are most disruptive to quality of life

  • Considers preferences, health history, and contraindications

  • Uses evidence-based options in a thoughtful, staged way

This is why menopause care often looks different from person to person.


A sleep-first lens

Sleep is often a key driver of other symptoms.

Fragmented or insufficient sleep can worsen:

  • Anxiety and emotional reactivity

  • Low mood

  • Concentration and memory efficiency

  • Stress tolerance

For this reason, clinical assessment frequently starts with understanding sleep patterns and contributors, even when mood or cognitive symptoms are the primary concern.


Non-pharmacological approaches

Insomnia-focused therapies

For women experiencing persistent insomnia, cognitive behavioural therapy for insomnia (CBT-I) is recognised as a first-line, evidence-based approach.

CBT-I focuses on:

  • Sleep behaviours and routines

  • Sleep drive and circadian timing

  • Thought patterns that perpetuate insomnia

International guidance recognises CBT-I — including menopause-specific CBT approaches — as appropriate for menopause-related sleep disturbance.


Lifestyle and behavioural strategies

Supportive strategies may include:

  • Establishing consistent sleep–wake times

  • Reducing factors that fragment sleep (such as alcohol sensitivity)

  • Managing cognitive and emotional load

  • Supporting stress regulation

These approaches are often used alongside other management options.


Hormonal therapy considerations

Hormonal changes during the menopause transition can increase sensitivity within sleep, mood, and cognitive systems.

For some women, menopausal hormone therapy (MHT) may be considered as part of management following careful individual assessment. International guidance recognises that addressing vasomotor symptoms may improve sleep and quality of life for some women.

However:

  • Hormones are rarely the only factor

  • Hormonal therapy is not appropriate for everyone

  • Benefits and risks must be considered individually

Hormonal therapy, where appropriate, is typically part of a broader management plan rather than a standalone solution.


Non-hormonal medical options

For women who are unable or prefer not to use hormone-based therapies, evidence-based non-hormonal options may be considered.

These may be used to support:

  • Vasomotor symptoms

  • Sleep disruption

  • Mood or anxiety symptoms

International menopause guidance recognises non-hormonal therapies as valid options when clinically appropriate.


Supporting mood, anxiety, and cognitive symptoms

Where anxiety, low mood, or cognitive symptoms are prominent, management may involve:

  • Addressing sleep disruption

  • Psychological or behavioural therapies

  • Reviewing contributing medical factors

  • Considering broader mental health supports where indicated

Distinguishing menopausal vulnerability from primary mental health conditions is an important part of assessment.


The importance of individualised care

Effective menopause care does not focus on a single symptom or system in isolation.

A structured approach considers:

  • Symptom patterns and severity

  • Sleep quality

  • Hormonal stage and symptoms

  • Physical and mental health history

  • Lifestyle context and stressors

  • Individual preferences and goals

This whole-picture approach is supported by current clinical guidance and reflects how menopause care is delivered in practice.


Key takeaway

Sleep disturbance, mood changes, anxiety, and cognitive symptoms during perimenopause and menopause are common, interconnected, and highly individual.

Evidence supports a stepwise, personalised approach that may include behavioural strategies, psychological therapies, hormonal and non-hormonal options, and lifestyle support — selected according to individual needs and circumstances.

If you would like to seek further information about these symptoms or learn more about assessment options, you can contact Menopause & Me:

You’re not alone on this journey: knowledge is power!


Warm Regards,

Jenna Bell

Nurse Practitioner & Menopause Educator


Sources

Australasian Menopause Society | International Menopause Society | North American Menopause Society | NICE Guidelines NG23


Important  Disclaimer: The information in this blog/newsletter is general in nature and intended for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your Nurse  Practitioner, doctor, or another qualified health practitioner with any questions you may have regarding a medical condition or before commencing any new treatment, exercise program, changing your diet, or taking supplements –  particularly if you have existing health conditions, are on medication, or have had fractures or falls in the past.  Individual needs and responses vary.


 
 
 

Comments


bottom of page